The importance of intensive lipid lowering in CV risk reduction: the role of early combination treatment

Professor Alberto Zambon explains the significance of intensive lipid lowering therapy in cardiovascular risk reduction after ESC 2023. He highlights the importance of early combination treatment to achieve target LDL- Ch levels. His key messages can be guidance for all of us. Video: https://medicaldigest.org/scientific-contents/interview:importance-intensive-lipid-lowering-cv-risk-reduction-role-early-combination-treatment